TY  - JOUR 
AU  - Redondo-Calvo, Francisco Javier
AU  - Pérez-Ortiz, José Manuel
AU  - Padín-Noriega, Juan Fernando
PY  - 2024
SN  - 1422-0067
UR  - http://hdl.handle.net/20.500.12020/1613
AB  - Aprotinin is a broad-spectrum inhibitor of human proteases that has been approved for
the treatment of bleeding in single coronary artery bypass surgery because of its potent
antifibrinolytic actions. Following the outbreak of the COVID-19 pandemic,...
LA  - en
PB  - MDPI
TI  - Aprotinin (II): Inhalational Administration for the Treatment of COVID-19 and Other Viral Conditions
DO  - https://doi.org/10.3390/ijms25137209
T2  - International Journal of Molecular Sciences
M2  - 7209
KW  - Proteases
KW  - Aprotinin
KW  - COVID-19
KW  - Kinin–kallikrein System (KKS)
KW  - Renin–angiotensin– aldosterone System (RAAS)
KW  - Angiotensin-converting Enzyme Type 2 (ACE2)
KW  - Antifibrinolytic
KW  - Inhalational Administration
KW  - Pharmacodynamic
KW  - Pharmacokinetic
VL  - 25
ER  -